These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 24144799)
1. Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity. Sun M; Tang Y; Ding T; Liu M; Wang X Fitoterapia; 2014 Jan; 92():1-8. PubMed ID: 24144799 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4. Jin C; He X; Zhang F; He L; Chen J; Wang L; An L; Fan Y Xenobiotica; 2015; 45(7):571-7. PubMed ID: 25811791 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes. Lou D; Bao SS; Li YH; Lin QM; Yang SF; He JY Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):611-618. PubMed ID: 30825074 [TBL] [Abstract][Full Text] [Related]
4. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms. Or PM; Lam FF; Kwan YW; Cho CH; Lau CP; Yu H; Lin G; Lau CB; Fung KP; Leung PC; Yeung JH Phytomedicine; 2012 Apr; 19(6):535-44. PubMed ID: 22261394 [TBL] [Abstract][Full Text] [Related]
5. Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes. Seervi M; Lotankar S; Barbar S; Sathaye S Drug Metab Pers Ther; 2016 Jun; 31(2):115-22. PubMed ID: 26959552 [TBL] [Abstract][Full Text] [Related]
6. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Eagling VA; Tjia JF; Back DJ Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang. Lee SY; Lee JY; Kang W; Kwon KI; Park SK; Oh SJ; Ma JY; Kim SK Food Chem Toxicol; 2013 Jan; 51():343-9. PubMed ID: 23104244 [TBL] [Abstract][Full Text] [Related]
8. Enzyme kinetic and molecular docking studies on the metabolic interactions of 1-hydroxy-2,3,5-trimethoxy-xanthone, isolated from Halenia elliptica D. Don, with model probe substrates of human cytochrome P450 enzymes. Feng R; Zhou X; Or PM; Ma JY; Tan XS; Fu J; Ma C; Shi JG; Che CT; Wang Y; Yeung JH Phytomedicine; 2012 Sep; 19(12):1125-33. PubMed ID: 22819301 [TBL] [Abstract][Full Text] [Related]
9. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats. Wang B; Yang S; Hu J; Li Y J Ethnopharmacol; 2014 Sep; 155(3):1473-82. PubMed ID: 25091466 [TBL] [Abstract][Full Text] [Related]
10. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes. Yeung JH; Or PM Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191 [TBL] [Abstract][Full Text] [Related]
11. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro. Wang X; Cheung CM; Lee WY; Or PM; Yeung JH Phytomedicine; 2010 Sep; 17(11):868-75. PubMed ID: 20638257 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes. Ramakrishna R; Bhateria M; Singh R; Bhatta RS J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941 [TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant human thymosin-alpha1, an immuno-modulating peptide with 28 amino acids, on the activity of cytochrome P450s. Wang B; He F; Lin Y; Huang M; Zhou SF Drug Metab Lett; 2007 Aug; 1(3):199-204. PubMed ID: 19356044 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of acacetin inhibition potential against cytochrome P450 in vitro and in vivo. Zhou Y; Tu Y; Zhou Q; Hua A; Geng P; Chen F; Han A; Liu J; Dai D; Wang S; Wang J; Wen C Chem Biol Interact; 2020 Sep; 329():109147. PubMed ID: 32738202 [TBL] [Abstract][Full Text] [Related]
15. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes. Wei J; Zhang H; Zhao Q Pharm Biol; 2018 Dec; 56(1):363-367. PubMed ID: 30122094 [TBL] [Abstract][Full Text] [Related]
16. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Kobayashi K; Urashima K; Shimada N; Chiba K Biochem Pharmacol; 2002 Mar; 63(5):889-96. PubMed ID: 11911841 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes. Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355 [TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9). Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863 [TBL] [Abstract][Full Text] [Related]
19. Investigation of cytochrome P450 inhibitory properties of maslinic acid, a bioactive compound from Olea europaea L., and its structure-activity relationship. Sun M; Tang Y; Ding T; Liu M; Wang X Phytomedicine; 2015 Jan; 22(1):56-65. PubMed ID: 25636872 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots. Wang Y; Wu S; Chen Z; Zhang H; Zhao W J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]